Evidence map›Paper›PMID 28552911›Full record

ArticleActa pharmacologica Sinica2017

Plumbagin suppresses chronic periodontitis in rats via down-regulation of TNF-α, IL-1β and IL-6 expression.

Xin-Yi Zheng, Chuan-Yuan Mao, Han Qiao, Xi Zhang, Li Yu, Ting-Yu Wang, Er-Yi Lu

Open access · bronzeAbstract read
In one paragraph

Article in Acta pharmacologica Sinica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. [Research Progress in the Molecular Regulatory Mechanisms of Alveolar Bone Restoration].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2024
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Xin-Yi ZhengDepartment of Stomatology, Renji Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai 200127, China.
Chuan-Yuan MaoCollege of Stomatology, Shanghai JiaoTong University School of Medicine, Shanghai 200025, China.
Han QiaoShanghai Key Laboratory of Orthopedic Implant, Department of Orthopedic Surgery, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai 200011, China.
Xi ZhangCollege of Stomatology, Shanghai JiaoTong University School of Medicine, Shanghai 200025, China.
Li YuDepartment of Stomatology, Renji Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai 200127, China.
Ting-Yu WangDepartment of Pharmacy, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai 200011, China.
Er-Yi LuDepartment of Stomatology, Renji Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai 200127, China.
Shanghai Jiao Tong University · CNRenji Hospital · CNShanghai Ninth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic periodontitis (CP) is one of the most common oral diseases, which causes alveolar bone absorption and tooth loss in adults. In this study we aimed to investigate the potential of plumbagin (PL), a widely-investigated active compound extracted from the traditional Chinese herb Plumbago zeylanica L in treating CP. Human periodontal ligament stem cells (PDLSCs) were used for in vitro studies, whereas an animal model of CP was established in SD rats by ligation+Porphyromonas gingivalis (Pg) stimulation. The rats were injected with PL (2, 4, and 6 mg·kg

Indexed as

AnimalsAnti-Inflammatory AgentsChemokine CCL2Chemokine CCL5Chronic PeriodontitisDose-Response Relationship, DrugDown-RegulationFemaleInterleukin-1betaInterleukin-6NaphthoquinonesPeriodontiumRatsRats, Sprague-DawleyTumor Necrosis Factor-alphaAnti-Inflammatory AgentsChemokine CCL2Chemokine CCL5Interleukin-1betaInterleukin-6NaphthoquinonesplumbaginTumor Necrosis Factor-alpha

Identifiers

PMID28552911
PMCPMC5547554
OpenAlexW2617698555

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.